欧洲哮喘药物市场预测至 2028 年 - COVID-19 影响和药物（快速缓解药物和长期控制药物）、给药途径（吸入、预装注射器/小瓶等）和分销渠道（在线药房）的区域分析、医院药房和零售药房）
No. of Pages: 150 | Report Code: BMIRE00025217 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIRE00025217 | Category: Life Sciences
市场的增长归因于哮喘患病率的上升和日益增长的哮喘发病率。暴露于粗颗粒物质。然而，未满足的医疗需求阻碍了市场的增长。
哮喘是一种自20世纪以来心理因素在其中发挥重要作用的疾病。临床医生知道，情绪压力会引发或加剧哮喘，而患者的心理健康会影响症状表现和治疗依从性，从而损害哮喘控制。因此，哮喘和心理问题之间存在双向联系。
哮喘和哮喘恶化与情绪高涨时期相关。根据各种患病率估计，抑郁症在哮喘患者中比在普通人群中更常见，其中一些患病率达到 40%。与一般人群相比，双相情感障碍患者罹患 IgE 介导的过敏性疾病（例如哮喘）的机会更高。焦虑症在哮喘中的患病率也较高，影响多达三分之一的哮喘儿童和青少年以及 24% 的哮喘成人。
疾病标准模糊、命名不一致、样本有限以及强调门诊或住院患者而不是社区，影响了对哮喘患者心理和精神障碍频率的研究。世界心理健康调查通过为全球 17 个国家提供标准化数据来解决其中一些方法论问题。与没有哮喘的个体相比，经年龄和性别调整后的精神障碍患病几率的汇总估计值，抑郁症为 1.6 (95% CI=1.4, 1.8)，焦虑症为 1.5 (95% CI=1.4,1.7)。本研究中哮喘与酒精使用障碍之间也存在关联（OR 1.7 (95% CI=1.4, 2.1)）。
尽管精神障碍和哮喘的发病率在不同国家之间差异很大，因此它们之间的横截面异质性要小得多。鉴于所代表的国家在文化、医疗保健组织和社会经济发展方面存在很大差异，这种一致性是值得注意的。它表明任何环境中的从业者都应该意识到哮喘与心理和精神疾病之间存在广泛的重叠。
早期的心身模型表明，心理不适与哮喘患者的哮喘发病率不同。然而，对病理生理学途径的新认识表明，心理变量也可能在哮喘的发生中发挥作用。神经内分泌应激反应、细胞因子和神经肽等关键生物系统的破坏类似于哮喘和严重的抑郁症。特应性症状和抑郁症状之间遗传关系的更多证据来自双胞胎研究。
由于哮喘和心理问题之间的联系，有时会采用心理疗法来补充哮喘药物治疗。行为疗法、认知疗法、认知行为疗法（CBT）、放松技巧、心理动力心理疗法和咨询（针对个人和家庭）都已被尝试过。与药物哮喘治疗不同，仍然缺乏关于心理社会治疗对儿童和成人有效性的证据。预计这将增加未来几年对哮喘治疗的需求，从而推动欧洲哮喘药物市场的发展。
欧洲哮喘药物市场细分
欧洲哮喘药物市场按药物划分，分为快速缓解药物和长期控制药物。根据给药途径，市场分为吸入型、预装注射器/小瓶等。 根据分销渠道，欧洲哮喘药物市场分为在线药房、医院药房和零售药房。按国家/地区划分，市场分为德国、西班牙、意大利、法国、英国和欧洲其他地区。
阿斯利康；梯瓦制药工业有限公司；
勃林格殷格翰国际有限公司；葛兰素史克公司；默克公司有限公司；皇家飞利浦公司；赛诺菲；
辉瑞公司 (Arena Pharmaceutical GmbH)；诺华公司；和雅培是欧洲哮喘药物市场的领先公司之一。
Strategic insights for Europe Asthma Drugs involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 6,876.65 Million |
| Market Size by 2028 | US$ 9,636.62 Million |
| Global CAGR (2021 - 2028) | 4.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Asthma Drugs refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Asthma Drugs Market is valued at US$ 6,876.65 Million in 2021, it is projected to reach US$ 9,636.62 Million by 2028.
As per our report Europe Asthma Drugs Market, the market size is valued at US$ 6,876.65 Million in 2021, projecting it to reach US$ 9,636.62 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Europe Asthma Drugs Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Asthma Drugs Market report:
The Europe Asthma Drugs Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Asthma Drugs Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Asthma Drugs Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Asthma Drugs Market
